Roflumilast (Roflumilast) (Tablets)


Indications and Reactions:

Role Indications Reactions
Primary
Chronic Obstructive Pulmonary Disease 97.0%
Asthma 0.9%
Bronchitis Chronic 0.4%
Condition Aggravated 0.4%
Cronobacter Infection 0.4%
Infection 0.4%
Respiratory Failure 0.4%
Condition Aggravated 10.8%
Nausea 9.7%
Diarrhoea 7.5%
Headache 7.5%
Vomiting 7.5%
Death 6.5%
Tremor 6.5%
Chronic Obstructive Pulmonary Disease 4.3%
Insomnia 4.3%
Abdominal Pain 3.2%
Decreased Appetite 3.2%
Depression 3.2%
Dizziness 3.2%
Epistaxis 3.2%
Gastrointestinal Disorder 3.2%
Gastrointestinal Haemorrhage 3.2%
General Physical Health Deterioration 3.2%
Malaise 3.2%
Myalgia 3.2%
Sleep Disorder 3.2%
Secondary
Chronic Obstructive Pulmonary Disease 100.0%
Diarrhoea 18.2%
Vomiting 18.2%
Biliary Fibrosis 9.1%
Blood Bilirubin Increased 9.1%
Blood Pressure Increased 9.1%
Cachexia 9.1%
Gamma-glutamyltransferase Increased 9.1%
Hepatic Siderosis 9.1%
Lung Disorder 9.1%

Drug Data